NACC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.437700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.097800E-01
Normal-vs-Stage2
2.098100E-03
Normal-vs-Stage3
8.426000E-01
Normal-vs-Stage4
9.760400E-01
Stage1-vs-Stage2
3.852000E-01
Stage1-vs-Stage3
9.421600E-01
Stage1-vs-Stage4
7.348400E-01
Stage2-vs-Stage3
5.768800E-01
Stage2-vs-Stage4
3.349400E-01
Stage3-vs-Stage4
8.362800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.262800E-03
Normal-vs-AfricanAmerican
3.980600E-01
Normal-vs-Asian
3.574100E-02
Caucasian-vs-AfricanAmerican
8.727800E-01
Caucasian-vs-Asian
5.230500E-02
AfricanAmerican-vs-Asian
1.057600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.261300E-03
Normal-vs-Female
7.200200E-03
Male-vs-Female
6.646800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.190000E-01
Normal-vs-Age(41-60Yrs)
2.046600E-01
Normal-vs-Age(61-80Yrs)
1.309580E-02
Normal-vs-Age(81-100Yrs)
1.901450E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.793000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.747400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.300400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.120600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.139800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.396600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.920240E-01
Normal-vs-Daily Drinker
1.803640E-01
Normal-vs-Weekly Drinker
1.302420E-02
Normal-vs-Occasional Drinker
6.718500E-03
Normal-vs-Social Drinker
3.833400E-01
Non Drinker-vs-Daily Drinker
9.461600E-01
Non Drinker-vs-Weekly Drinker
1.361200E-01
Non Drinker-vs-Occasional Drinker
1.640050E-01
Non Drinker-vs-Social Drinker
7.144800E-01
Daily Drinker-vs-Weekly Drinker
1.465600E-01
Daily Drinker-vs-Occasional Drinker
1.804160E-01
Daily Drinker-vs-Social Drinker
7.521200E-01
Weekly Drinker-vs-Occasional Drinker
8.045000E-01
Weekly Drinker-vs-Social Drinker
2.285000E-01
Occasional Drinker-vs-Social Drinker
2.950000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.329400E-01
Normal-vs-Grade 2
5.764400E-01
Normal-vs-Grade 3
1.021160E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.382100E-02
Grade 1-vs-Grade 3
9.738500E-02
Grade 1-vs-Grade 4
3.329400E-01
Grade 2-vs-Grade 3
7.504200E-01
Grade 2-vs-Grade 4
5.764400E-01
Grade 3-vs-Grade 4
1.021160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.294100E-02
Normal-vs-NonDiabetic
1.501020E-03
Diabetic-vs-NonDiabetic
4.069800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.420390E-02
Normal-vs-NoPancreatitis
7.562700E-03
Pancreatitis-vs-NoPancreatitis
1.588840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.859400E-03
Normal-vs-N1
3.502600E-03
N0-vs-N1
9.951400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.407000E-01
Normal-vs-TP53-NonMutant
9.064000E-01
TP53-Mutant-vs-TP53-NonMutant
6.231200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
